Track topics on Twitter Track topics that are important to you
OncoSec Medical (NASDAQ: ONCS) has named former Advaxis (NASDAQ: ADXS) CEO Daniel J. O’Conner to take over as chief executive at the San Diego-based company, which has been developing technology to enhance the delivery and uptake of its anti-tumor drug therapies. O’Conner resigned in July from Advaxis, a cancer immunotherapy biotech in Princeton, NJ, and […]
Original Article: OncoSec Medical Names Former Advaxis Exec O’Conner as CEONEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...